Non-viral methods for gene transfer towards osteosarcoma therapy

Journal of Drug Targeting

Volumn 15, Issue 3, 2007, Pages 184-189

  Dass, Crispin R ^a   Choong, Peter F M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Antisense; Cancer; Gene therapy; Non viral; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLODEXTRIN; DOXORUBICIN; ENDOSTATIN; IFOSFAMIDE; INTERLEUKIN 12; LIPOSOME; METHOTREXATE; MICROSPHERE; PLASMID DNA; POLYETHYLENEIMINE; PROTEIN P53; UROKINASE RECEPTOR; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; FEASIBILITY STUDY; GENE CONSTRUCT; GENE TRANSFER; HUMAN; IN VIVO STUDY; INFANCY; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG METASTASIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OSTEOSARCOMA; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; VIRAL GENE DELIVERY SYSTEM;

BONE NEOPLASMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; OSTEOSARCOMA;

EID: 34147149638     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701231547     Document Type: Review

References (39)

1. Barzon, L., Stefani, AL, Pacenti, M. and Palu, G. (2005) Versatility of gene therapy vectors through viruses. Expert Opin Biol Ther, 5:5, pp. 639-662.
2. Benjamin, R., Helman, L., Meyers, P. and Reaman, G. (2001) A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung. Hum Gene Ther, 12:12, pp. 1591-1593.
3. Cheon, J., Ko, SC, Gardner, TA, Shirakawa, T., Gotoh, A., Kao, C. and Chung, LW (1997) Chemogene therapy: Osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model. Cancer Gene Ther, 4:6, pp. 359-365.
4. Cichutek, K. (2006) Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis. Dev Biol (Basel), 123, pp. 29-34.
5. Dass, CR (1997) Cationic liposomes and gene therapy for solid tumors. Drug Delivery, 4, pp. 151-165.
6. Dass, CR (2002) Vehicles for oligonucleotide delivery to tumours. J Pharm Pharmacol, 54, pp. 3-27.
7. Dass, CR (2004) Oligonucleotide delivery to tumours using macromolecular carriers. Biotechnol Appl Biochem, 40, pp. 113-122.
8. Dass, CR (2004) Cyclodextrins and oligonucleotide delivery to solid tumours. J Drug Target, 12:1, pp. 1-9.
9. Dass, CR (2006) Preclinical anticancer activity of DNA-based cleavage molecules. Drug Dev Ind Pharm, 32:1, pp. 1-5.
10. Dass, CR and Burton, MA (2002) A model for evaluating selective delivery of plasmid DNA to tumours via the vasculature. Cancer Biother Radiopharm, 17:5, pp. 501-505.
11. Dass, CR and Burton, MA (2003) Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo. J Pharm Pharmacol, 55:1, pp. 19-25.
12. Dass, CR and Choong, PF (2006) Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability. J Control Release, 113:2, pp. 155-163.
13. Dass, CR and Choong, PF (2006) Carrier-mediated delivery of peptidic drugs for cancer therapy. Peptides
14. Dass, CR and Choong, PF (2006) Biophysical delivery of peptides: Applicability for cancer therapy. Peptides
15. Dass, CR, Saravolac, EG and Sun, LQ (2002) Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev, 12:5, pp. 289-299.
16. Dass, CR, Nadesapillai, AP, Robin, D., Howard, ML, Fisher, JL, Zhou, H. and Choong, PF (2005) Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma. Clin Exp Metastasis, 22:8, pp. 643-652.
17. Dass, CR, Ek, ET and Choong, PF (2006) Human xenograft osteosarcoma models with spontaneous metastasis in mice: Clinical relevance and applicability for drug testing. J Cancer Res Clin Oncol, p. 132.
18. Dass, CR, Ek, ET, Contreras, KG and Choong, PF (2006) A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis, p. 23.
19. Densmore, CL, Kleinerman, ES, Gautam, A., Jia, SF, Worth, LL, Waldrep, JC, Fung, YK, T'Ang, A. and Knight, V. (2001) Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Ther, 8:9, pp. 619-627.
20. Duan, X., Jia, SF, Koshkina, N. and Kleinerman, ES (2006) Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer, 106:6, pp. 1382-1388.
21. Dutour, A., Rabinovich-Chable, H., Kaletta, C., Michaelis, U., Fiorenza, F., Sturtz, F. and Rigaud, M. (2004) Is troponin I gene therapy effective for osteosarcoma treatment? Study on a human-like orthotopic rat model. Anticancer Res, 24:6, pp. 3977-3982.
22. Dutour, A., Monteil, J., Paraf, F., Charissoux, JL, Kaletta, C., Sauer, B., Naujoks, K. and Rigaud, M. (2005) Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: Study in a human-like rat orthotopic tumor. Mol Ther, 11:2, pp. 311-319.
23. Ek, ET and Choong, PF (2006) The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas. Expert Rev Anticancer Ther, 6:2, pp. 225-237.
24. Fahmy, RG, Dass, CR, Sun, LQ, Chesterman, CN and Khachigian, LM (2003) Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med, 9:8, pp. 1026-1032.
25. Felgner, PL, Gadek, TR, Holm, M., Roman, R., Chan, HW, Wenz, M., Northrop, JP, Ringold, GM and Danielsen, M. (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA, 84:21, pp. 7413-7417.
26. Fisher, JL, Mackie, PS, Howard, ML, Zhou, H. and Choong, PF (2001) The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: An in vivo mouse model. Clin Cancer Res, 7:6, pp. 1654-1660.
27. Jia, SF, Worth, LL and Kleinerman, ES (1999) A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis, 17:6, pp. 501-506.
28. Jia, SF, Worth, LL, Densmore, CL, Zhou, Z. and Kleinerman, ES (2002) Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther, 9:3, pp. 260-266.
29. Khan, AU (2006) Ribozyme: A clinical tool. Clin Chim Acta, 367:1, pp. 20-27.
30. Lachman, HM, Cheng, GH and Skoultchi, AI (1986) Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate. Proc Natl Acad Sci USA, 83:17, pp. 6480-6484.
31. Link, MP, Goorin, AM and Miser, AW (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med, 314:25, pp. 1600-1606.
32. Longhi, A., Errani, C., De Paolis, M., Mercuri, M. and Bacci, G. (2006) Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev, 32:6, pp. 423-436.
33. Luu, HH, Kang, Q., Park, JK, Luo, Q., Jiang, W., Yin, H., Montag, AG, Simon, MA, Peabody, TD, Haydon, RC, Rinker-Schaeffer, CW and He, TC (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis, 22:4, pp. 319-329.
34. Nimjee, SM, Rusconi, CP and Sullenger, BA (2005) Aptamers: An emerging class of therapeutics. Annu Rev Med, 56, pp. 555-583.
35. Putral, LN and McMillan, NA (2006) RNA interference for the treatment of cancer. Drug News Perspect, 19:6, pp. 317-324.
36. Thomas, M., Lu, JJ, Chen, J. and Klibanov, AM (2005) Cross-linked small polyethylenimines: While still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res, 22:3, pp. 373-380.
37. Wacheck, V. and Zangemeister-Wittke, U. (2006) Antisense molecules for targeted cancer therapy. Crit Rev Oncol Hematol, 59:1, pp. 65-73.
38. Walker, TL, Dass, CR and Burton, MA (2002) Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotides. Anticancer Res, 22:4, pp. 2237-2245.
39. Witlox, MA, Lamfers, ML, Wuisman, PI, Curiel, DT and Siegal, GP (2006) Evolving gene therapy approaches for osteosarcoma using viral vectors: Review. Bone